enVVeno Medical (NVNO) Net Equity Issued and Repurchased (2017 - 2024)
enVVeno Medical's (NVNO) quarterly Net Equity Issued and Repurchased came in at $13.6 million in Q3 2024, up 1960.8% quarter-over-quarter from $659500.0 in Q4 2017.
enVVeno Medical (NVNO) Net Equity Issued and Repurchased (2017 - 2024) Analysis & Trends
enVVeno Medical's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $13.6 million for Q3 2024.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $13.6 million in Q3 2024; TTM through Sep 2024 was $13.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $782000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $13.6 million in Q3 2024 per NVNO's latest filing, from $659500.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $13.6 million in Q3 2024 and bottomed at $13.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 13.59 Mn |
| Sep 30, 2024 | 13.59 Mn |
| Dec 31, 2017 | 659,500.00 |
| Dec 31, 2017 | 659,500.00 |